These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

321 related items for PubMed ID: 15087667

  • 21. Concomitant KIT/BRAF and PDGFRA/BRAF mutations are rare events in gastrointestinal stromal tumors.
    Rossi S, Sbaraglia M, Dell'Orto MC, Gasparotto D, Cacciatore M, Boscato E, Carraro V, Toffolatti L, Gallina G, Niero M, Pilozzi E, Mandolesi A, Sessa F, Sonzogni A, Mancini C, Mazzoleni G, Romeo S, Maestro R, Dei Tos AP.
    Oncotarget; 2016 May 24; 7(21):30109-18. PubMed ID: 27097112
    [Abstract] [Full Text] [Related]

  • 22. [The importance of mutational status in prognosis and therapy of GIST].
    Comandone A, Boglione A.
    Recenti Prog Med; 2015 Jan 24; 106(1):17-22. PubMed ID: 25621775
    [Abstract] [Full Text] [Related]

  • 23. Prognostic value of KIT/PDGFRA mutations in gastrointestinal stromal tumours (GIST): Polish Clinical GIST Registry experience.
    Wozniak A, Rutkowski P, Piskorz A, Ciwoniuk M, Osuch C, Bylina E, Sygut J, Chosia M, Rys J, Urbanczyk K, Kruszewski W, Sowa P, Siedlecki J, Debiec-Rychter M, Limon J, Polish Clinical GIST Registry.
    Ann Oncol; 2012 Feb 24; 23(2):353-60. PubMed ID: 21527588
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis.
    Miettinen M, Lasota J.
    Arch Pathol Lab Med; 2006 Oct 24; 130(10):1466-78. PubMed ID: 17090188
    [Abstract] [Full Text] [Related]

  • 26. KIT and PDGFRA mutations in gastrointestinal stromal tumors (GISTs).
    Lasota J, Miettinen M.
    Semin Diagn Pathol; 2006 May 24; 23(2):91-102. PubMed ID: 17193822
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. BRAF mutations in KIT/PDGFRA positive gastrointestinal stromal tumours (GISTs): Is their frequency underestimated?
    Jašek K, Váňová B, Grendár M, Štanclová A, Szépe P, Hornáková A, Holubeková V, Plank L, Lasabová Z.
    Pathol Res Pract; 2020 Nov 24; 216(11):153171. PubMed ID: 32836055
    [Abstract] [Full Text] [Related]

  • 31. [Clinicopathological features and prognosis of gastrointestinal stromal tumor with PDGFRA-D842V mutation].
    Li XQ, Tu L, Wang M, Ma XL, Yang LX, Shen YY, Zhuang C, Zhao WY, Qiu JF, Zhao G, Cao H.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Sep 25; 23(9):872-879. PubMed ID: 32927512
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. PDGFRA and KIT Mutation Status and Its Association With Clinicopathological Properties, Including DOG1.
    Baskin Y, Kocal GC, Kucukzeybek BB, Akbarpour M, Kayacik N, Sagol O, Ellidokuz H, Oztop I.
    Oncol Res; 2016 Sep 25; 24(1):41-53. PubMed ID: 27178821
    [Abstract] [Full Text] [Related]

  • 34. Detection of mutations in the BRAF gene in patients with KIT and PDGFRA wild-type gastrointestinal stromal tumors.
    Jasek K, Buzalkova V, Minarik G, Stanclova A, Szepe P, Plank L, Lasabova Z.
    Virchows Arch; 2017 Jan 25; 470(1):29-36. PubMed ID: 27864688
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Mutations in exon 11 of the c-kit gene in a myogenic tumor and a neurogenic tumor as well as in gastrointestinal stromal tumors. Utility of c-kit mutation as a prognostic biomarker for gastrointestinal mesenchymal tumor.
    Yasuoka R, Sakakura C, Shimomura K, Fujita Y, Nakanishi M, Aragane H, Hagiwara A, Bamba M, Abe T, Yamagishi H.
    Dig Surg; 2003 Jan 25; 20(3):183-91. PubMed ID: 12759497
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Low frequency of MAP kinase pathway alterations in KIT and PDGFRA wild-type GISTs.
    Martinho O, Gouveia A, Viana-Pereira M, Silva P, Pimenta A, Reis RM, Lopes JM.
    Histopathology; 2009 Jul 25; 55(1):53-62. PubMed ID: 19614767
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.